Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upfront Dexrazoxane with Doxorubicin in Soft Tissue Sarcoma
NCT02584309Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2016
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexrazoxane in soft tissue sarcoma (STS), sponsored by Washington University School of Medicine. Started Feb 2016; status: completed.
02
Drugs
dexrazoxane
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02584309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584309.